194 related articles for article (PubMed ID: 29577474)
1. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
2. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
6. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
8. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
Zeng SY; Liu T; Meng WT; Chen YN
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
[TBL] [Abstract][Full Text] [Related]
9. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic Value of G and GM Tests in Acute Leukemia Patients with Invasive Fungal Disease].
Qian KY; Lyu QX; Dai LJ; Chang HR; Wu DP; Sun AN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1678-1681. PubMed ID: 31607331
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.
Angebault C; Lanternier F; Dalle F; Schrimpf C; Roupie AL; Dupuis A; Agathine A; Scemla A; Paubelle E; Caillot D; Neven B; Frange P; Suarez F; d'Enfert C; Lortholary O; Bougnoux ME
Open Forum Infect Dis; 2016 Sep; 3(3):ofw128. PubMed ID: 27419189
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
15. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.
Hammarström H; Kondori N; Friman V; Wennerås C
Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):917-25. PubMed ID: 25573536
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
Koo S; Bryar JM; Page JH; Baden LR; Marty FM
Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
[TBL] [Abstract][Full Text] [Related]
19. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis.
Vidal-García M; Domingo MP; De Rueda B; Roc L; Delgado MP; Revillo MJ; Pardo J; Gálvez EM; Rezusta A
Appl Microbiol Biotechnol; 2016 Mar; 100(5):2327-34. PubMed ID: 26678078
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of serum galactomannan and β-D-glucan for invasive aspergillosis in suspected patients: A meta-analysis.
Huang QY; Li PC; Yue JR
Medicine (Baltimore); 2024 Feb; 103(5):e37067. PubMed ID: 38306560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
